nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—epilepsy syndrome	0.342	1	CbGaD
Clodronate—SLC25A6—hindbrain—epilepsy syndrome	0.0109	0.0904	CbGeAlD
Clodronate—SLC25A6—brainstem—epilepsy syndrome	0.00624	0.0518	CbGeAlD
Clodronate—SLC25A6—forebrain—epilepsy syndrome	0.00602	0.05	CbGeAlD
Clodronate—SLC25A6—telencephalon—epilepsy syndrome	0.00554	0.046	CbGeAlD
Clodronate—SLC25A5—forebrain—epilepsy syndrome	0.00524	0.0435	CbGeAlD
Clodronate—SLC25A4—Phenelzine—Lacosamide—epilepsy syndrome	0.00499	1	CbGdCrCtD
Clodronate—SLC25A4—forebrain—epilepsy syndrome	0.00491	0.0407	CbGeAlD
Clodronate—SLC25A5—telencephalon—epilepsy syndrome	0.00482	0.04	CbGeAlD
Clodronate—SLC25A4—telencephalon—epilepsy syndrome	0.00451	0.0375	CbGeAlD
Clodronate—SLC25A6—spinal cord—epilepsy syndrome	0.00388	0.0322	CbGeAlD
Clodronate—SLC25A5—medulla oblongata—epilepsy syndrome	0.00378	0.0314	CbGeAlD
Clodronate—SLC25A4—medulla oblongata—epilepsy syndrome	0.00355	0.0294	CbGeAlD
Clodronate—SLC25A5—midbrain—epilepsy syndrome	0.00346	0.0287	CbGeAlD
Clodronate—SLC25A6—head—epilepsy syndrome	0.00345	0.0286	CbGeAlD
Clodronate—SLC25A5—spinal cord—epilepsy syndrome	0.00337	0.028	CbGeAlD
Clodronate—SLC25A6—nervous system—epilepsy syndrome	0.00327	0.0271	CbGeAlD
Clodronate—SLC25A4—midbrain—epilepsy syndrome	0.00324	0.0269	CbGeAlD
Clodronate—SLC25A4—spinal cord—epilepsy syndrome	0.00316	0.0262	CbGeAlD
Clodronate—SLC25A6—central nervous system—epilepsy syndrome	0.00315	0.0261	CbGeAlD
Clodronate—SLC25A6—cerebellum—epilepsy syndrome	0.00308	0.0255	CbGeAlD
Clodronate—SLC25A5—head—epilepsy syndrome	0.003	0.0249	CbGeAlD
Clodronate—SLC25A5—nervous system—epilepsy syndrome	0.00284	0.0236	CbGeAlD
Clodronate—SLC25A4—head—epilepsy syndrome	0.00281	0.0233	CbGeAlD
Clodronate—SLC25A5—central nervous system—epilepsy syndrome	0.00274	0.0227	CbGeAlD
Clodronate—SLC25A5—cerebellum—epilepsy syndrome	0.00268	0.0222	CbGeAlD
Clodronate—SLC25A4—nervous system—epilepsy syndrome	0.00266	0.0221	CbGeAlD
Clodronate—SLC25A4—central nervous system—epilepsy syndrome	0.00256	0.0213	CbGeAlD
Clodronate—SLC25A4—cerebellum—epilepsy syndrome	0.00251	0.0208	CbGeAlD
Clodronate—SLC25A6—brain—epilepsy syndrome	0.0025	0.0207	CbGeAlD
Clodronate—SLC25A5—brain—epilepsy syndrome	0.00217	0.018	CbGeAlD
Clodronate—SLC25A4—brain—epilepsy syndrome	0.00204	0.0169	CbGeAlD
Clodronate—PTGS2—forebrain—epilepsy syndrome	0.000986	0.00819	CbGeAlD
Clodronate—PTGS2—telencephalon—epilepsy syndrome	0.000907	0.00753	CbGeAlD
Clodronate—PTGS2—medulla oblongata—epilepsy syndrome	0.000712	0.00592	CbGeAlD
Clodronate—PTGS2—midbrain—epilepsy syndrome	0.000651	0.00541	CbGeAlD
Clodronate—PTGS2—spinal cord—epilepsy syndrome	0.000635	0.00527	CbGeAlD
Clodronate—PTGS2—head—epilepsy syndrome	0.000565	0.00469	CbGeAlD
Clodronate—PTGS2—nervous system—epilepsy syndrome	0.000535	0.00444	CbGeAlD
Clodronate—PTGS2—central nervous system—epilepsy syndrome	0.000515	0.00428	CbGeAlD
Clodronate—PTGS2—cerebellum—epilepsy syndrome	0.000504	0.00418	CbGeAlD
Clodronate—PTGS2—brain—epilepsy syndrome	0.000409	0.0034	CbGeAlD
Clodronate—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000355	0.00128	CcSEcCtD
Clodronate—Dyspnoea—Diazepam—epilepsy syndrome	0.000354	0.00127	CcSEcCtD
Clodronate—Urticaria—Propofol—epilepsy syndrome	0.000353	0.00127	CcSEcCtD
Clodronate—Skin disorder—Clonazepam—epilepsy syndrome	0.000352	0.00127	CcSEcCtD
Clodronate—Vomiting—Lacosamide—epilepsy syndrome	0.000351	0.00126	CcSEcCtD
Clodronate—Blood creatinine increased—Topiramate—epilepsy syndrome	0.000351	0.00126	CcSEcCtD
Clodronate—Abdominal pain—Propofol—epilepsy syndrome	0.000351	0.00126	CcSEcCtD
Clodronate—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000351	0.00126	CcSEcCtD
Clodronate—Dyspepsia—Diazepam—epilepsy syndrome	0.00035	0.00126	CcSEcCtD
Clodronate—Nausea—Rufinamide—epilepsy syndrome	0.00035	0.00126	CcSEcCtD
Clodronate—Dehydration—Topiramate—epilepsy syndrome	0.000349	0.00125	CcSEcCtD
Clodronate—Rash—Lacosamide—epilepsy syndrome	0.000348	0.00125	CcSEcCtD
Clodronate—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000348	0.00125	CcSEcCtD
Clodronate—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000348	0.00125	CcSEcCtD
Clodronate—Dermatitis—Lacosamide—epilepsy syndrome	0.000348	0.00125	CcSEcCtD
Clodronate—Anorexia—Clonazepam—epilepsy syndrome	0.000346	0.00124	CcSEcCtD
Clodronate—Decreased appetite—Diazepam—epilepsy syndrome	0.000345	0.00124	CcSEcCtD
Clodronate—Pneumonia—Gabapentin—epilepsy syndrome	0.000345	0.00124	CcSEcCtD
Clodronate—Urticaria—Midazolam—epilepsy syndrome	0.000345	0.00124	CcSEcCtD
Clodronate—Anorexia—Phenytoin—epilepsy syndrome	0.000344	0.00123	CcSEcCtD
Clodronate—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000343	0.00123	CcSEcCtD
Clodronate—Dyspnoea—Felbamate—epilepsy syndrome	0.000343	0.00123	CcSEcCtD
Clodronate—Abdominal pain upper—Topiramate—epilepsy syndrome	0.000342	0.00123	CcSEcCtD
Clodronate—Infection—Carbamazepine—epilepsy syndrome	0.000342	0.00123	CcSEcCtD
Clodronate—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000342	0.00123	CcSEcCtD
Clodronate—Vomiting—Clobazam—epilepsy syndrome	0.000341	0.00123	CcSEcCtD
Clodronate—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000339	0.00122	CcSEcCtD
Clodronate—Dyspepsia—Felbamate—epilepsy syndrome	0.000339	0.00122	CcSEcCtD
Clodronate—Rash—Clobazam—epilepsy syndrome	0.000338	0.00122	CcSEcCtD
Clodronate—Dermatitis—Clobazam—epilepsy syndrome	0.000338	0.00121	CcSEcCtD
Clodronate—Renal failure—Gabapentin—epilepsy syndrome	0.000338	0.00121	CcSEcCtD
Clodronate—Dyspnoea—Zonisamide—epilepsy syndrome	0.000336	0.00121	CcSEcCtD
Clodronate—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000335	0.0012	CcSEcCtD
Clodronate—Decreased appetite—Felbamate—epilepsy syndrome	0.000334	0.0012	CcSEcCtD
Clodronate—Skin disorder—Carbamazepine—epilepsy syndrome	0.000334	0.0012	CcSEcCtD
Clodronate—Pharyngitis—Pregabalin—epilepsy syndrome	0.000334	0.0012	CcSEcCtD
Clodronate—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000332	0.00119	CcSEcCtD
Clodronate—Dyspepsia—Zonisamide—epilepsy syndrome	0.000331	0.00119	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.000331	0.00119	CcSEcCtD
Clodronate—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.00033	0.00119	CcSEcCtD
Clodronate—Infection—Lamotrigine—epilepsy syndrome	0.00033	0.00119	CcSEcCtD
Clodronate—Urethral disorder—Pregabalin—epilepsy syndrome	0.00033	0.00118	CcSEcCtD
Clodronate—Urticaria—Fosphenytoin—epilepsy syndrome	0.000329	0.00118	CcSEcCtD
Clodronate—Nausea—Lacosamide—epilepsy syndrome	0.000328	0.00118	CcSEcCtD
Clodronate—Anorexia—Carbamazepine—epilepsy syndrome	0.000328	0.00118	CcSEcCtD
Clodronate—Decreased appetite—Zonisamide—epilepsy syndrome	0.000327	0.00118	CcSEcCtD
Clodronate—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000327	0.00118	CcSEcCtD
Clodronate—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000325	0.00117	CcSEcCtD
Clodronate—Dysphagia—Topiramate—epilepsy syndrome	0.000324	0.00116	CcSEcCtD
Clodronate—Dyspnoea—Clonazepam—epilepsy syndrome	0.000323	0.00116	CcSEcCtD
Clodronate—Dyspnoea—Phenytoin—epilepsy syndrome	0.000321	0.00115	CcSEcCtD
Clodronate—Urticaria—Vigabatrin—epilepsy syndrome	0.000321	0.00115	CcSEcCtD
Clodronate—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.00032	0.00115	CcSEcCtD
Clodronate—Dyspepsia—Clonazepam—epilepsy syndrome	0.000319	0.00115	CcSEcCtD
Clodronate—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000319	0.00115	CcSEcCtD
Clodronate—Nausea—Clobazam—epilepsy syndrome	0.000319	0.00115	CcSEcCtD
Clodronate—Dyspepsia—Phenytoin—epilepsy syndrome	0.000317	0.00114	CcSEcCtD
Clodronate—Anorexia—Lamotrigine—epilepsy syndrome	0.000317	0.00114	CcSEcCtD
Clodronate—Urticaria—Diazepam—epilepsy syndrome	0.000316	0.00113	CcSEcCtD
Clodronate—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000316	0.00113	CcSEcCtD
Clodronate—Decreased appetite—Clonazepam—epilepsy syndrome	0.000315	0.00113	CcSEcCtD
Clodronate—Pruritus—Propofol—epilepsy syndrome	0.000314	0.00113	CcSEcCtD
Clodronate—Abdominal pain—Diazepam—epilepsy syndrome	0.000314	0.00113	CcSEcCtD
Clodronate—Decreased appetite—Phenytoin—epilepsy syndrome	0.000313	0.00113	CcSEcCtD
Clodronate—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000313	0.00113	CcSEcCtD
Clodronate—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000312	0.00112	CcSEcCtD
Clodronate—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000311	0.00112	CcSEcCtD
Clodronate—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000309	0.00111	CcSEcCtD
Clodronate—Pruritus—Midazolam—epilepsy syndrome	0.000307	0.0011	CcSEcCtD
Clodronate—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000307	0.0011	CcSEcCtD
Clodronate—Pharyngitis—Gabapentin—epilepsy syndrome	0.000306	0.0011	CcSEcCtD
Clodronate—Urticaria—Felbamate—epilepsy syndrome	0.000306	0.0011	CcSEcCtD
Clodronate—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000304	0.00109	CcSEcCtD
Clodronate—Abdominal pain—Felbamate—epilepsy syndrome	0.000304	0.00109	CcSEcCtD
Clodronate—Vomiting—Acetazolamide—epilepsy syndrome	0.000304	0.00109	CcSEcCtD
Clodronate—Diarrhoea—Propofol—epilepsy syndrome	0.000304	0.00109	CcSEcCtD
Clodronate—Pruritus—Levetiracetam—epilepsy syndrome	0.000304	0.00109	CcSEcCtD
Clodronate—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000303	0.00109	CcSEcCtD
Clodronate—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000303	0.00109	CcSEcCtD
Clodronate—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000303	0.00109	CcSEcCtD
Clodronate—Urethral disorder—Gabapentin—epilepsy syndrome	0.000302	0.00109	CcSEcCtD
Clodronate—Anaemia—Valproic Acid—epilepsy syndrome	0.000299	0.00108	CcSEcCtD
Clodronate—Urticaria—Zonisamide—epilepsy syndrome	0.000299	0.00107	CcSEcCtD
Clodronate—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000299	0.00107	CcSEcCtD
Clodronate—Abdominal pain—Zonisamide—epilepsy syndrome	0.000298	0.00107	CcSEcCtD
Clodronate—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000297	0.00107	CcSEcCtD
Clodronate—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000296	0.00107	CcSEcCtD
Clodronate—Angioedema—Valproic Acid—epilepsy syndrome	0.000296	0.00106	CcSEcCtD
Clodronate—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000294	0.00106	CcSEcCtD
Clodronate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000293	0.00105	CcSEcCtD
Clodronate—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000293	0.00105	CcSEcCtD
Clodronate—Pneumonia—Topiramate—epilepsy syndrome	0.000291	0.00104	CcSEcCtD
Clodronate—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000289	0.00104	CcSEcCtD
Clodronate—Urticaria—Clonazepam—epilepsy syndrome	0.000288	0.00104	CcSEcCtD
Clodronate—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000287	0.00103	CcSEcCtD
Clodronate—Abdominal pain—Clonazepam—epilepsy syndrome	0.000287	0.00103	CcSEcCtD
Clodronate—Urticaria—Phenytoin—epilepsy syndrome	0.000286	0.00103	CcSEcCtD
Clodronate—Pruritus—Vigabatrin—epilepsy syndrome	0.000286	0.00103	CcSEcCtD
Clodronate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000285	0.00102	CcSEcCtD
Clodronate—Renal failure—Topiramate—epilepsy syndrome	0.000284	0.00102	CcSEcCtD
Clodronate—Nausea—Acetazolamide—epilepsy syndrome	0.000284	0.00102	CcSEcCtD
Clodronate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000283	0.00102	CcSEcCtD
Clodronate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000283	0.00102	CcSEcCtD
Clodronate—Vomiting—Propofol—epilepsy syndrome	0.000282	0.00101	CcSEcCtD
Clodronate—Pruritus—Diazepam—epilepsy syndrome	0.000281	0.00101	CcSEcCtD
Clodronate—Rash—Propofol—epilepsy syndrome	0.00028	0.00101	CcSEcCtD
Clodronate—Dermatitis—Propofol—epilepsy syndrome	0.00028	0.00101	CcSEcCtD
Clodronate—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000278	0.000999	CcSEcCtD
Clodronate—Vomiting—Midazolam—epilepsy syndrome	0.000276	0.000993	CcSEcCtD
Clodronate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000276	0.000993	CcSEcCtD
Clodronate—Rash—Midazolam—epilepsy syndrome	0.000274	0.000985	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000274	0.000984	CcSEcCtD
Clodronate—Dermatitis—Midazolam—epilepsy syndrome	0.000274	0.000984	CcSEcCtD
Clodronate—Urticaria—Carbamazepine—epilepsy syndrome	0.000273	0.000982	CcSEcCtD
Clodronate—Vomiting—Levetiracetam—epilepsy syndrome	0.000273	0.00098	CcSEcCtD
Clodronate—Pruritus—Felbamate—epilepsy syndrome	0.000272	0.000978	CcSEcCtD
Clodronate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000272	0.000977	CcSEcCtD
Clodronate—Diarrhoea—Diazepam—epilepsy syndrome	0.000272	0.000977	CcSEcCtD
Clodronate—Rash—Levetiracetam—epilepsy syndrome	0.000271	0.000972	CcSEcCtD
Clodronate—Anaemia—Pregabalin—epilepsy syndrome	0.00027	0.000972	CcSEcCtD
Clodronate—Dermatitis—Levetiracetam—epilepsy syndrome	0.00027	0.000971	CcSEcCtD
Clodronate—Angioedema—Pregabalin—epilepsy syndrome	0.000267	0.000961	CcSEcCtD
Clodronate—Pruritus—Zonisamide—epilepsy syndrome	0.000266	0.000957	CcSEcCtD
Clodronate—Urticaria—Lamotrigine—epilepsy syndrome	0.000264	0.000949	CcSEcCtD
Clodronate—Nausea—Propofol—epilepsy syndrome	0.000264	0.000948	CcSEcCtD
Clodronate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000263	0.000946	CcSEcCtD
Clodronate—Diarrhoea—Felbamate—epilepsy syndrome	0.000263	0.000946	CcSEcCtD
Clodronate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000263	0.000945	CcSEcCtD
Clodronate—Infection—Valproic Acid—epilepsy syndrome	0.000262	0.000943	CcSEcCtD
Clodronate—Rash—Fosphenytoin—epilepsy syndrome	0.000261	0.000938	CcSEcCtD
Clodronate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000261	0.000937	CcSEcCtD
Clodronate—Nausea—Midazolam—epilepsy syndrome	0.000258	0.000928	CcSEcCtD
Clodronate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000258	0.000926	CcSEcCtD
Clodronate—Pharyngitis—Topiramate—epilepsy syndrome	0.000257	0.000925	CcSEcCtD
Clodronate—Pruritus—Clonazepam—epilepsy syndrome	0.000257	0.000923	CcSEcCtD
Clodronate—Vomiting—Vigabatrin—epilepsy syndrome	0.000257	0.000922	CcSEcCtD
Clodronate—Skin disorder—Valproic Acid—epilepsy syndrome	0.000257	0.000922	CcSEcCtD
Clodronate—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000256	0.000921	CcSEcCtD
Clodronate—Pruritus—Phenytoin—epilepsy syndrome	0.000255	0.000916	CcSEcCtD
Clodronate—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000255	0.000916	CcSEcCtD
Clodronate—Nausea—Levetiracetam—epilepsy syndrome	0.000255	0.000916	CcSEcCtD
Clodronate—Rash—Vigabatrin—epilepsy syndrome	0.000254	0.000915	CcSEcCtD
Clodronate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000254	0.000914	CcSEcCtD
Clodronate—Urethral disorder—Topiramate—epilepsy syndrome	0.000254	0.000914	CcSEcCtD
Clodronate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000254	0.000912	CcSEcCtD
Clodronate—Vomiting—Diazepam—epilepsy syndrome	0.000253	0.000908	CcSEcCtD
Clodronate—Anorexia—Valproic Acid—epilepsy syndrome	0.000252	0.000905	CcSEcCtD
Clodronate—Rash—Diazepam—epilepsy syndrome	0.000251	0.0009	CcSEcCtD
Clodronate—Dermatitis—Diazepam—epilepsy syndrome	0.00025	0.0009	CcSEcCtD
Clodronate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000248	0.000892	CcSEcCtD
Clodronate—Anaemia—Gabapentin—epilepsy syndrome	0.000248	0.000891	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000247	0.000889	CcSEcCtD
Clodronate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000247	0.000886	CcSEcCtD
Clodronate—Nausea—Fosphenytoin—epilepsy syndrome	0.000246	0.000884	CcSEcCtD
Clodronate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000245	0.000882	CcSEcCtD
Clodronate—Angioedema—Gabapentin—epilepsy syndrome	0.000245	0.000881	CcSEcCtD
Clodronate—Vomiting—Felbamate—epilepsy syndrome	0.000245	0.000879	CcSEcCtD
Clodronate—Pruritus—Carbamazepine—epilepsy syndrome	0.000243	0.000875	CcSEcCtD
Clodronate—Rash—Felbamate—epilepsy syndrome	0.000242	0.000872	CcSEcCtD
Clodronate—Dermatitis—Felbamate—epilepsy syndrome	0.000242	0.000871	CcSEcCtD
Clodronate—Nausea—Vigabatrin—epilepsy syndrome	0.00024	0.000862	CcSEcCtD
Clodronate—Vomiting—Zonisamide—epilepsy syndrome	0.000239	0.00086	CcSEcCtD
Clodronate—Rash—Zonisamide—epilepsy syndrome	0.000237	0.000853	CcSEcCtD
Clodronate—Infection—Pregabalin—epilepsy syndrome	0.000237	0.000853	CcSEcCtD
Clodronate—Dermatitis—Zonisamide—epilepsy syndrome	0.000237	0.000852	CcSEcCtD
Clodronate—Nausea—Diazepam—epilepsy syndrome	0.000236	0.000848	CcSEcCtD
Clodronate—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000236	0.000847	CcSEcCtD
Clodronate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000235	0.000846	CcSEcCtD
Clodronate—Pruritus—Lamotrigine—epilepsy syndrome	0.000235	0.000845	CcSEcCtD
Clodronate—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000234	0.00084	CcSEcCtD
Clodronate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000233	0.000836	CcSEcCtD
Clodronate—Skin disorder—Pregabalin—epilepsy syndrome	0.000232	0.000834	CcSEcCtD
Clodronate—Vomiting—Clonazepam—epilepsy syndrome	0.000231	0.000829	CcSEcCtD
Clodronate—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00023	0.000825	CcSEcCtD
Clodronate—Vomiting—Phenytoin—epilepsy syndrome	0.000229	0.000824	CcSEcCtD
Clodronate—Rash—Clonazepam—epilepsy syndrome	0.000229	0.000822	CcSEcCtD
Clodronate—Dermatitis—Clonazepam—epilepsy syndrome	0.000229	0.000821	CcSEcCtD
Clodronate—Nausea—Felbamate—epilepsy syndrome	0.000228	0.000821	CcSEcCtD
Clodronate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000228	0.00082	CcSEcCtD
Clodronate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000228	0.000819	CcSEcCtD
Clodronate—Anorexia—Pregabalin—epilepsy syndrome	0.000228	0.000818	CcSEcCtD
Clodronate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000227	0.000818	CcSEcCtD
Clodronate—Rash—Phenytoin—epilepsy syndrome	0.000227	0.000817	CcSEcCtD
Clodronate—Dermatitis—Phenytoin—epilepsy syndrome	0.000227	0.000816	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000227	0.000815	CcSEcCtD
Clodronate—Rash—Oxcarbazepine—epilepsy syndrome	0.000226	0.000812	CcSEcCtD
Clodronate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000226	0.000812	CcSEcCtD
Clodronate—Nausea—Zonisamide—epilepsy syndrome	0.000224	0.000804	CcSEcCtD
Clodronate—Vomiting—Carbamazepine—epilepsy syndrome	0.000219	0.000786	CcSEcCtD
Clodronate—Infection—Gabapentin—epilepsy syndrome	0.000218	0.000782	CcSEcCtD
Clodronate—Rash—Carbamazepine—epilepsy syndrome	0.000217	0.00078	CcSEcCtD
Clodronate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000217	0.000779	CcSEcCtD
Clodronate—Nausea—Clonazepam—epilepsy syndrome	0.000215	0.000775	CcSEcCtD
Clodronate—Nausea—Phenytoin—epilepsy syndrome	0.000214	0.000769	CcSEcCtD
Clodronate—Dyspnoea—Pregabalin—epilepsy syndrome	0.000213	0.000765	CcSEcCtD
Clodronate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000213	0.000765	CcSEcCtD
Clodronate—Skin disorder—Gabapentin—epilepsy syndrome	0.000213	0.000765	CcSEcCtD
Clodronate—Vomiting—Lamotrigine—epilepsy syndrome	0.000211	0.00076	CcSEcCtD
Clodronate—Urticaria—Valproic Acid—epilepsy syndrome	0.00021	0.000754	CcSEcCtD
Clodronate—Rash—Lamotrigine—epilepsy syndrome	0.00021	0.000753	CcSEcCtD
Clodronate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000209	0.000753	CcSEcCtD
Clodronate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000209	0.000751	CcSEcCtD
Clodronate—Anorexia—Gabapentin—epilepsy syndrome	0.000209	0.00075	CcSEcCtD
Clodronate—Anaemia—Topiramate—epilepsy syndrome	0.000209	0.00075	CcSEcCtD
Clodronate—Decreased appetite—Pregabalin—epilepsy syndrome	0.000208	0.000746	CcSEcCtD
Clodronate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000206	0.000741	CcSEcCtD
Clodronate—Nausea—Carbamazepine—epilepsy syndrome	0.000204	0.000734	CcSEcCtD
Clodronate—Nausea—Lamotrigine—epilepsy syndrome	0.000197	0.00071	CcSEcCtD
Clodronate—Dyspnoea—Gabapentin—epilepsy syndrome	0.000195	0.000702	CcSEcCtD
Clodronate—Dyspepsia—Gabapentin—epilepsy syndrome	0.000193	0.000693	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000191	0.000686	CcSEcCtD
Clodronate—Decreased appetite—Gabapentin—epilepsy syndrome	0.00019	0.000684	CcSEcCtD
Clodronate—Urticaria—Pregabalin—epilepsy syndrome	0.00019	0.000682	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000189	0.00068	CcSEcCtD
Clodronate—Abdominal pain—Pregabalin—epilepsy syndrome	0.000189	0.000679	CcSEcCtD
Clodronate—Pruritus—Valproic Acid—epilepsy syndrome	0.000187	0.000672	CcSEcCtD
Clodronate—Infection—Topiramate—epilepsy syndrome	0.000183	0.000658	CcSEcCtD
Clodronate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000181	0.00065	CcSEcCtD
Clodronate—Skin disorder—Topiramate—epilepsy syndrome	0.000179	0.000643	CcSEcCtD
Clodronate—Anorexia—Topiramate—epilepsy syndrome	0.000176	0.000631	CcSEcCtD
Clodronate—Urticaria—Gabapentin—epilepsy syndrome	0.000174	0.000625	CcSEcCtD
Clodronate—Abdominal pain—Gabapentin—epilepsy syndrome	0.000173	0.000622	CcSEcCtD
Clodronate—Pruritus—Pregabalin—epilepsy syndrome	0.000169	0.000607	CcSEcCtD
Clodronate—Vomiting—Valproic Acid—epilepsy syndrome	0.000168	0.000604	CcSEcCtD
Clodronate—Rash—Valproic Acid—epilepsy syndrome	0.000167	0.000599	CcSEcCtD
Clodronate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000166	0.000598	CcSEcCtD
Clodronate—Dyspnoea—Topiramate—epilepsy syndrome	0.000164	0.00059	CcSEcCtD
Clodronate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000163	0.000587	CcSEcCtD
Clodronate—Dyspepsia—Topiramate—epilepsy syndrome	0.000162	0.000583	CcSEcCtD
Clodronate—Decreased appetite—Topiramate—epilepsy syndrome	0.00016	0.000576	CcSEcCtD
Clodronate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000159	0.000572	CcSEcCtD
Clodronate—Nausea—Valproic Acid—epilepsy syndrome	0.000157	0.000564	CcSEcCtD
Clodronate—Pruritus—Gabapentin—epilepsy syndrome	0.000155	0.000557	CcSEcCtD
Clodronate—Vomiting—Pregabalin—epilepsy syndrome	0.000152	0.000546	CcSEcCtD
Clodronate—Rash—Pregabalin—epilepsy syndrome	0.000151	0.000541	CcSEcCtD
Clodronate—Dermatitis—Pregabalin—epilepsy syndrome	0.00015	0.000541	CcSEcCtD
Clodronate—Diarrhoea—Gabapentin—epilepsy syndrome	0.00015	0.000539	CcSEcCtD
Clodronate—Urticaria—Topiramate—epilepsy syndrome	0.000146	0.000526	CcSEcCtD
Clodronate—Abdominal pain—Topiramate—epilepsy syndrome	0.000146	0.000524	CcSEcCtD
Clodronate—Nausea—Pregabalin—epilepsy syndrome	0.000142	0.00051	CcSEcCtD
Clodronate—Vomiting—Gabapentin—epilepsy syndrome	0.000139	0.0005	CcSEcCtD
Clodronate—Rash—Gabapentin—epilepsy syndrome	0.000138	0.000496	CcSEcCtD
Clodronate—Dermatitis—Gabapentin—epilepsy syndrome	0.000138	0.000496	CcSEcCtD
Clodronate—Pruritus—Topiramate—epilepsy syndrome	0.00013	0.000469	CcSEcCtD
Clodronate—Nausea—Gabapentin—epilepsy syndrome	0.00013	0.000468	CcSEcCtD
Clodronate—Diarrhoea—Topiramate—epilepsy syndrome	0.000126	0.000453	CcSEcCtD
Clodronate—Vomiting—Topiramate—epilepsy syndrome	0.000117	0.000421	CcSEcCtD
Clodronate—Rash—Topiramate—epilepsy syndrome	0.000116	0.000418	CcSEcCtD
Clodronate—Dermatitis—Topiramate—epilepsy syndrome	0.000116	0.000417	CcSEcCtD
Clodronate—Nausea—Topiramate—epilepsy syndrome	0.000109	0.000393	CcSEcCtD
Clodronate—SLC25A5—Metabolism—SLC2A1—epilepsy syndrome	9.56e-05	0.000375	CbGpPWpGaD
Clodronate—SLC25A6—Disease—JUNB—epilepsy syndrome	9.5e-05	0.000373	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PLCB1—epilepsy syndrome	9.46e-05	0.000371	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS1—epilepsy syndrome	9.43e-05	0.00037	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TH—epilepsy syndrome	9.43e-05	0.00037	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	9.24e-05	0.000363	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	9.14e-05	0.000359	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	9.07e-05	0.000356	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HBEGF—epilepsy syndrome	9e-05	0.000353	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP2D6—epilepsy syndrome	8.86e-05	0.000348	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT3—epilepsy syndrome	8.83e-05	0.000347	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HES1—epilepsy syndrome	8.8e-05	0.000345	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ADAM10—epilepsy syndrome	8.63e-05	0.000339	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FYN—epilepsy syndrome	8.56e-05	0.000336	CbGpPWpGaD
Clodronate—SLC25A5—Disease—H2AFX—epilepsy syndrome	8.53e-05	0.000335	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ADRA2A—epilepsy syndrome	8.44e-05	0.000331	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—POMC—epilepsy syndrome	8.42e-05	0.000331	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—BCHE—epilepsy syndrome	8.4e-05	0.00033	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CCL2—epilepsy syndrome	8.24e-05	0.000323	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	8.23e-05	0.000323	CbGpPWpGaD
Clodronate—SLC25A5—Disease—YWHAZ—epilepsy syndrome	8.23e-05	0.000323	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDC42—epilepsy syndrome	8.06e-05	0.000316	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—SLC2A1—epilepsy syndrome	8.01e-05	0.000315	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	7.97e-05	0.000313	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PLCB1—epilepsy syndrome	7.93e-05	0.000311	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CCR5—epilepsy syndrome	7.92e-05	0.000311	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCG2—epilepsy syndrome	7.91e-05	0.000311	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TH—epilepsy syndrome	7.9e-05	0.00031	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HMOX1—epilepsy syndrome	7.87e-05	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	7.87e-05	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	7.85e-05	0.000308	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—AGT—epilepsy syndrome	7.81e-05	0.000307	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	7.79e-05	0.000306	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CAT—epilepsy syndrome	7.76e-05	0.000305	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2C19—epilepsy syndrome	7.71e-05	0.000303	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP11A1—epilepsy syndrome	7.67e-05	0.000301	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	7.57e-05	0.000297	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCB1—epilepsy syndrome	7.55e-05	0.000296	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SLC2A1—epilepsy syndrome	7.47e-05	0.000293	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JUNB—epilepsy syndrome	7.42e-05	0.000291	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HES1—epilepsy syndrome	7.38e-05	0.00029	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS1—epilepsy syndrome	7.36e-05	0.000289	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TSC2—epilepsy syndrome	7.36e-05	0.000289	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	7.26e-05	0.000285	CbGpPWpGaD
Clodronate—SLC25A5—Disease—APOE—epilepsy syndrome	7.2e-05	0.000283	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	7.19e-05	0.000282	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FYN—epilepsy syndrome	7.17e-05	0.000282	CbGpPWpGaD
Clodronate—SLC25A6—Disease—H2AFX—epilepsy syndrome	7.15e-05	0.000281	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	7.07e-05	0.000277	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HBEGF—epilepsy syndrome	7.02e-05	0.000276	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GPX1—epilepsy syndrome	7.02e-05	0.000275	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	6.93e-05	0.000272	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2D6—epilepsy syndrome	6.92e-05	0.000272	CbGpPWpGaD
Clodronate—SLC25A6—Disease—YWHAZ—epilepsy syndrome	6.9e-05	0.000271	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT3—epilepsy syndrome	6.89e-05	0.000271	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6ST—epilepsy syndrome	6.76e-05	0.000265	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ADAM10—epilepsy syndrome	6.73e-05	0.000264	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—epilepsy syndrome	6.71e-05	0.000263	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CCR5—epilepsy syndrome	6.63e-05	0.00026	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	6.6e-05	0.000259	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—epilepsy syndrome	6.59e-05	0.000259	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADRA2A—epilepsy syndrome	6.59e-05	0.000258	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—POMC—epilepsy syndrome	6.58e-05	0.000258	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—BCHE—epilepsy syndrome	6.56e-05	0.000257	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	6.55e-05	0.000257	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CAT—epilepsy syndrome	6.5e-05	0.000255	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CCL2—epilepsy syndrome	6.43e-05	0.000253	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—epilepsy syndrome	6.33e-05	0.000248	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDC42—epilepsy syndrome	6.29e-05	0.000247	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	6.29e-05	0.000247	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SLC2A1—epilepsy syndrome	6.26e-05	0.000246	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PLCB1—epilepsy syndrome	6.19e-05	0.000243	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TSC2—epilepsy syndrome	6.17e-05	0.000242	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TH—epilepsy syndrome	6.17e-05	0.000242	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AGT—epilepsy syndrome	6.16e-05	0.000242	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	6.11e-05	0.00024	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA13—epilepsy syndrome	6.1e-05	0.000239	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	6.06e-05	0.000238	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—epilepsy syndrome	6.03e-05	0.000237	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—epilepsy syndrome	6.03e-05	0.000237	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GPX1—epilepsy syndrome	5.88e-05	0.000231	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	5.84e-05	0.000229	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HES1—epilepsy syndrome	5.76e-05	0.000226	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	5.75e-05	0.000225	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	5.67e-05	0.000222	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6ST—epilepsy syndrome	5.67e-05	0.000222	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—epilepsy syndrome	5.62e-05	0.000221	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FYN—epilepsy syndrome	5.6e-05	0.00022	CbGpPWpGaD
Clodronate—SLC25A4—Disease—H2AFX—epilepsy syndrome	5.58e-05	0.000219	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDXK—epilepsy syndrome	5.52e-05	0.000217	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	5.5e-05	0.000216	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FGF2—epilepsy syndrome	5.47e-05	0.000215	CbGpPWpGaD
Clodronate—SLC25A4—Disease—YWHAZ—epilepsy syndrome	5.38e-05	0.000211	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	5.34e-05	0.00021	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	5.32e-05	0.000209	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	5.31e-05	0.000208	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	5.25e-05	0.000206	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	5.18e-05	0.000203	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—POMC—epilepsy syndrome	5.18e-05	0.000203	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CCR5—epilepsy syndrome	5.18e-05	0.000203	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AGT—epilepsy syndrome	5.16e-05	0.000202	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMOX1—epilepsy syndrome	5.15e-05	0.000202	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CAT—epilepsy syndrome	5.08e-05	0.000199	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—epilepsy syndrome	5.05e-05	0.000198	CbGpPWpGaD
Clodronate—PTGS2—Disease—PNPO—epilepsy syndrome	5.05e-05	0.000198	CbGpPWpGaD
Clodronate—PTGS2—Disease—EPM2A—epilepsy syndrome	5.05e-05	0.000198	CbGpPWpGaD
Clodronate—PTGS2—Disease—NHLRC1—epilepsy syndrome	5.05e-05	0.000198	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTOR—epilepsy syndrome	4.98e-05	0.000195	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	4.97e-05	0.000195	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCB1—epilepsy syndrome	4.94e-05	0.000194	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—epilepsy syndrome	4.93e-05	0.000194	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.91e-05	0.000193	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TSC2—epilepsy syndrome	4.81e-05	0.000189	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—epilepsy syndrome	4.72e-05	0.000185	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—epilepsy syndrome	4.71e-05	0.000185	CbGpPWpGaD
Clodronate—PTGS2—Disease—SV2A—epilepsy syndrome	4.69e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PDXK—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADK—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FAR1—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CERS1—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLUD1—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	4.62e-05	0.000181	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPX1—epilepsy syndrome	4.59e-05	0.00018	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FGF2—epilepsy syndrome	4.58e-05	0.00018	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6ST—epilepsy syndrome	4.42e-05	0.000174	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—epilepsy syndrome	4.39e-05	0.000172	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—POMC—epilepsy syndrome	4.34e-05	0.00017	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	4.23e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—EPM2A—epilepsy syndrome	4.23e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GAMT—epilepsy syndrome	4.23e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PNPO—epilepsy syndrome	4.23e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Disease—PFKL—epilepsy syndrome	4.18e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTOR—epilepsy syndrome	4.17e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—epilepsy syndrome	4.13e-05	0.000162	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—epilepsy syndrome	4.13e-05	0.000162	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.04e-05	0.000158	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AGT—epilepsy syndrome	4.03e-05	0.000158	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SRC—epilepsy syndrome	3.99e-05	0.000157	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—epilepsy syndrome	3.96e-05	0.000155	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—epilepsy syndrome	3.95e-05	0.000155	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	3.93e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA4—epilepsy syndrome	3.93e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—QDPR—epilepsy syndrome	3.93e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	3.92e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Disease—STX1B—epilepsy syndrome	3.83e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	3.71e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COX3—epilepsy syndrome	3.7e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	3.61e-05	0.000142	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FGF2—epilepsy syndrome	3.58e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—GBE1—epilepsy syndrome	3.56e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP1R3C—epilepsy syndrome	3.56e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Disease—CPSF4—epilepsy syndrome	3.56e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	3.53e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	3.5e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—KCNB1—epilepsy syndrome	3.5e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PFKL—epilepsy syndrome	3.5e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	3.5e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	3.5e-05	0.000137	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—epilepsy syndrome	3.46e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.42e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.4e-05	0.000134	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—POMC—epilepsy syndrome	3.39e-05	0.000133	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SRC—epilepsy syndrome	3.34e-05	0.000131	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTOR—epilepsy syndrome	3.26e-05	0.000128	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—epilepsy syndrome	3.23e-05	0.000127	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UPB1—epilepsy syndrome	3.2e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ATIC—epilepsy syndrome	3.2e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NEU1—epilepsy syndrome	3.2e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.19e-05	0.000125	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—epilepsy syndrome	3.09e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	3.08e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.03e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	2.98e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GBE1—epilepsy syndrome	2.98e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Disease—ST3GAL3—epilepsy syndrome	2.96e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.91e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	2.85e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ASAH1—epilepsy syndrome	2.8e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STXBP1—epilepsy syndrome	2.72e-05	0.000107	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—epilepsy syndrome	2.7e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.67e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NT5E—epilepsy syndrome	2.65e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALAD—epilepsy syndrome	2.65e-05	0.000104	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—epilepsy syndrome	2.61e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.59e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	2.53e-05	9.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	2.53e-05	9.94e-05	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—epilepsy syndrome	2.48e-05	9.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	2.48e-05	9.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADSL—epilepsy syndrome	2.43e-05	9.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLUL—epilepsy syndrome	2.38e-05	9.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	2.34e-05	9.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.32e-05	9.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.26e-05	8.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	2.19e-05	8.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EIF2AK2—epilepsy syndrome	2.15e-05	8.46e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AQP1—epilepsy syndrome	2.12e-05	8.33e-05	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—epilepsy syndrome	2.08e-05	8.16e-05	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—epilepsy syndrome	2.08e-05	8.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.04e-05	8e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPIA—epilepsy syndrome	1.99e-05	7.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.94e-05	7.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.92e-05	7.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.92e-05	7.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.79e-05	7.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.75e-05	6.87e-05	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—epilepsy syndrome	1.74e-05	6.83e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—epilepsy syndrome	1.62e-05	6.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.56e-05	6.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.52e-05	5.98e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.52e-05	5.95e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.5e-05	5.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.48e-05	5.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—JUNB—epilepsy syndrome	1.47e-05	5.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS1—epilepsy syndrome	1.46e-05	5.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.44e-05	5.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HBEGF—epilepsy syndrome	1.39e-05	5.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.37e-05	5.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.37e-05	5.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT3—epilepsy syndrome	1.36e-05	5.35e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—epilepsy syndrome	1.36e-05	5.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADAM10—epilepsy syndrome	1.33e-05	5.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.3e-05	5.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.3e-05	5.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDC42—epilepsy syndrome	1.24e-05	4.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.24e-05	4.85e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.22e-05	4.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TH—epilepsy syndrome	1.22e-05	4.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—epilepsy syndrome	1.14e-05	4.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FYN—epilepsy syndrome	1.11e-05	4.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—H2AFX—epilepsy syndrome	1.1e-05	4.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.06e-05	4.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CCR5—epilepsy syndrome	1.02e-05	4.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.02e-05	3.99e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAT—epilepsy syndrome	1e-05	3.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—epilepsy syndrome	9.77e-06	3.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TSC2—epilepsy syndrome	9.52e-06	3.74e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—epilepsy syndrome	9.31e-06	3.66e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—epilepsy syndrome	9.08e-06	3.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6ST—epilepsy syndrome	8.75e-06	3.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—epilepsy syndrome	8.68e-06	3.41e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AGT—epilepsy syndrome	7.96e-06	3.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—epilepsy syndrome	7.8e-06	3.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF2—epilepsy syndrome	7.08e-06	2.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—POMC—epilepsy syndrome	6.7e-06	2.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTOR—epilepsy syndrome	6.44e-06	2.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—epilepsy syndrome	6.11e-06	2.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—epilepsy syndrome	5.16e-06	2.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—epilepsy syndrome	3.21e-06	1.26e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.69e-06	1.05e-05	CbGpPWpGaD
